Accuray (ARAY) Shares Outstanding (2010 - 2026)
Accuray (ARAY) posted Shares Outstanding (Entity) of $119.4 million for Q2 2026, little changed on a QoQ basis from $118.9 million in Q1 2026, and up 6.03% year-over-year from $112.6 million in Q2 2025.
Analysis
Accuray (ARAY) Shares Outstanding (2010 - 2026) Analysis & Trends
Accuray has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $119.4 million in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 6.03% year-over-year to $119.4 million in Q2 2026; TTM through Jun 2026 was $119.4 million, a 6.03% increase from a year earlier, with the FY2026 full-year figure at $119.4 million, up 6.03% from the prior year.
- Shares Outstanding (Entity) was $119.4 million for Q2 2026 at Accuray, roughly flat from $118.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $119.4 million in Q2 2026, with the low at $92.8 million in Q1 2022.
- Average Shares Outstanding (Entity) over 5 years is $102.9 million, with a median of $99.7 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) dropped 0.49% in 2022, then grew 15.63% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $95.5 million in 2022, then grew by 3.84% to $99.2 million in 2023, then gained by 3.68% to $102.8 million in 2024, then gained by 15.54% to $118.8 million in 2025, then grew by 0.54% to $119.4 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $119.4 million (Q2 2026), $118.9 million (Q1 2026), and $118.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Accuray | 31.12 Mn | -11.20 Mn | - | 122.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.64 Mn |
| Mar 31, 2026 | 124.30 Mn |
| Dec 31, 2025 | 120.97 Mn |
| Sep 30, 2025 | 118.95 Mn |
| Jun 30, 2025 | 102.77 Mn |
| Mar 31, 2025 | 102.83 Mn |
| Dec 31, 2024 | 101.41 Mn |
| Sep 30, 2024 | 100.23 Mn |
| Jun 30, 2024 | 98.27 Mn |
| Mar 31, 2024 | 99.20 Mn |
| Dec 31, 2023 | 97.78 Mn |
| Sep 30, 2023 | 96.56 Mn |
| Jun 30, 2023 | 94.88 Mn |
| Mar 31, 2023 | 95.52 Mn |
| Dec 31, 2022 | 94.57 Mn |
| Sep 30, 2022 | 93.53 Mn |
| Jun 30, 2022 | 92.10 Mn |
| Mar 31, 2022 | 92.76 Mn |
| Dec 31, 2021 | 91.76 Mn |
| Sep 30, 2021 | 90.84 Mn |